Accretive Health (AH) Tops Q3 EPS by 1c, Maintains Guidance
Tweet Send to a Friend
Accretive Health (NYSE: AH) reported Q3 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
